Risk factors of renal cell carcinoma in a cohort of Sri Lankan patients: A case-control study. Keywords : ['sri lankan patient', 'renal cell carcinoma', 'risk factor', 'casecontrol study', 'cohort'] Author : B Balagobi 26
Risk factors of renal cell carcinoma in a cohort of Sri Lankan patients: A case-control study. Keywords : ['sri lankan patient', 'renal cell carcinoma', 'risk factor', 'casecontrol study', 'cohort'] Author : B Balagobi 26
Risk factors of renal cell carcinoma in a cohort of Sri Lankan patients: A case-control study. Keywords : ['sri lankan patient', 'renal cell carcinoma', 'risk factor', 'casecontrol study', 'cohort'] Author : B Balagobi 26
Risk factors of renal cell carcinoma in a cohort of Sri Lankan patients: A case-control study. Keywords : ['sri lankan patient', 'renal cell carcinoma', 'risk factor', 'casecontrol study', 'cohort'] Author : B Balagobi 26
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 25
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 26
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 24
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 27
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 26
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabetes', 'indian cohort', 'baseline characteristic'] Author : S Shah 27
